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The relative contribution ftwo neuronal .~urface pretenses, plasmin and a pretense with thrombin-like specificity, on NB2a/dl neutoblastoma 
migration and neuritogengsis were xamined. Exogenoua plasmin induced cell body rounding and increased cell migration, but did not prevent 
or reverse neurite outgrowth. Inhibition of endogenous plasmin by its specific inhibitor, aprotinin, suppressed migration but did not induce 
neuritogenesis. Removal or inhibition of the thrombin-like pretense by serum deprivation or hirudin addition, respectively, induced neurite 
outgrowth, as shown in our previous studie~, but did not suppress migration. By contrast, trypsin induced simultaneous cell rounding and neurite 
retraction. These findingB indicated that plasmin may regulate cell migration, while the thrombin.like protease may regulate facets of neurite 
outgrowth. Although unable to induce de nero neurito~enesis, plasmin inhibition potentiated the otherwise transient eurites induced by simulta- 
neou~ inhibition of the thrombin-like pretense. Since cultured neuronal cells migrate primarily in the direction of newly elaborated neurites, this 
findin~ iz interpreted to indleate that cessation ofneuronal migration by plasmin inhibition enhances n t neurite outgrowth by inhibition of the 
putative thrombin-like pretense. 
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1. INTRODUCTION 
Proteolysis is instrumental at several stages during 
neuronal differentiation and neurite outgrowth (for re- 
view, see [1]). Neurons release proteases [2-10], certain 
of which regulate the turnover of specific membrane 
proteins, and the inhibition of these proteases up- 
presses neuroblast migration and fosters the establish- 
ment of minor neuritic processes [2,11-19]. Two pro- 
teases which play regulatory roles in these processes are 
plasmin and thrombin (or an undisclosed pretense with 
thrombin-like specificity). 
The cell-mediated conversion of the zymogen plas- 
minogen to the active enzyme plasmin is accomplished 
by specific ell-associated and urokinase-type lasmino- 
gen activators (for review, see [20]), both types of which 
are expressed by a variety of cultured neuronal cells, 
including granule neurons [5], sympathetic and sensory 
neurons [21,22] and neuroblastoma [23]. Since plasmin 
is capable of hydrolyzing components of the extracellu- 
lar matrix, the conversion of plasminogen into the ae- 
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tive plasmin by these activators has been suggested to 
play a key role in the timing of cell migration [6,7,20]. 
Thrombin, or a thrombin-like nzyme, present on the 
outer plasma membrane surface or as a serum compo- 
nent, has been implicated in the regulation of neurite 
outgrowth, since the specific thrombin inhibitor, hi- 
rudin, induces neuritogenesis a effectively as serum de- 
pletion [16,24,25], and exogenous thrombin prevents or 
reverses neuritogenesis in some [11,25,26] but not all 
[16] neuroblastoma cultures. The mRNA for the throm- 
bin zymogen, prothrombin, has been demonstrated in
both rat and human brain [25]. Thrombin has also been 
shown to inactivate fibroblast growth factor, a known 
neurite-promoting agent [27]° suggesting that it may 
regulate neuritogenesis at multiple levels. 
While differential expression of surface pretenses 
such as plasmin and thrombin undoubtedly accompa- 
nies neuronal differentiation, the localized secretion by 
glial cells of specific inhibitors of these pretenses pro- 
foundly influences the timing of neuronal development 
and maturation. Glial cells secrete protease inhibitors, 
termed 'nexins' [28], which promote neurite formation 
and possess potent inhibitory activity against tissue 
plasminogen activator, urokinase, and thrombin 
[1,26,29-32]. Since nexins are 10-1"old more effective in- 
hibitors ofthrombin than ofplasmin [I], they may func- 
tion chiefly to inhibit thrombin activity; non-nexin in- 
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hibitors o f  plasminogen act ivators are also secreted by 
glial cells [33]. Glial cells also secrete extracellular ma-  
trix components  (for review, see [34]) which, by  provid- 
ing a more adhesive substrate, foster nearitogenesis, 
and stabilize otherwise transient neurites elaborated by 
some neuronal  cells in response to pretense inhibitors 
[17,35]. Local ized appl ication o f  protease inhibitors [36] 
can also influence the direction o f  neurite outgrowth.  
Furthermore,  secreted pretense inhibitors can bind to 
the extracellular matrix and this binding increases their 
inhibitor activity and alters their specificity [37]. 
In  some cell culture systems, increased plasmin acti- 
vation enhances neurite outgrowth [2,12,35]. Moreover ,  
p lasminogen activators become localized to the growth 
cone [23], leading to the addit ional suggestion [1] that  
the growth cone may represent a structure that contin-  
ues migrat ing despite the cessation o f  migrat ion of  the 
neuronal  cell body. In other cell culture systems, how-  
ever, neurite outgrowth was attr ibuted to inhibition o f  
thrombin (e.g. [16,17,32]). Inhibit ion o f  thrombin pro-  
motes the elaboration o f  transient neurites in neuroblas-  
tome cells [17]; these transient neurites can be stabilized 
by an addit ional class o f  inhibitors, active against eel- 
pain but not  thrombin,  that are themselves incapable o f  
inducing neuritogenesis [16]. 
In the present study, we demonstrate  that  plasmin 
activity modulates cell adhesion and migration in 
NB2a/d l  neuroblastoma cells, but does not prevent or 
reverse neurite outgrowth,  while, as we have previously 
demonstrated,  the activity o f  a thrombin- l ike pretense 
exhibits the opposite behaviour.  Our  results, and those 
of  the above studies, underscore the l ikel ihood that the 
events o f  neurite initiation and cont inued elaborat ion 
are control led by a balance o f  multiple proteases and 
their inhibitors. 
2. EXPERIMENTAL  
2.1. Cell~' al~d culture conditions 
NB2a/dl cells [17.35] were maintained in Dulbee¢o's Modified 
Eagle's M~ium (DMEM) containing 10% fetal call" serum and 25 
/~g/ml Geatamycin (Sigma Chemical Co., St. Louis, MO) in a humid- 
ifi~:l atmosphere of95% air and 5% CO,. 
2.2. l"reatmcnt of ne, roblantoma cells with pretenses and lnhibltors 
To assay the effect o(exogenous pretenses and protease inhibitors, 
cells were plated at a density of 10a/plata in 35-ram: plates or 10:/well 
in 24-x~ell trays in 1 ml ofthe above medium. Twenty-four hours later, 
the medium was replaced with medium containing either 0.8% serum, 
which is sufficient o maintain cell division and prevent neurite out- 
growth, but permissive for the effects of various proteases and inhib. 
itors [16], or no serum, to induce the laboration o(axonal neurites 
[15]. At this time, triplicate cultures received one or more of the 
following: thrombin (0.1-10 U/ml), plasmin (0.1-10 U/ml), hiradin (5 
U/ml), aprotinin (0.1-1.0 U/ml), trypsin (0.1-10 U/ml). All compo- 
nents were obtained (rein Sigma. 
2.3. Quantitatlon of neuronal morphology and neurite length 
At 4 or 24 h after the above treatments, dupli~t¢ cultures were 
rinsed in Tris-batTered saline (TBS; pH 7.4), fixed for !0 rain in 4% 
paraformaldehyde in 0.1 M phosphate buffer (pH 7.2) a~. room tem- 
perature for 15 rain, then rinsed and stored in TBS as described 
previously [15]. Between 100-200 cells in each of the fixed cultures 
mere examined byphase-contrast microscopy for neuronal morphol- 
ogy and neurit¢ length. The relative number of cells possessing 
rounded soma (defined. and readily detectable y, their characteristic 
phase-dark, refractile appearance v rsus the phase-lucent appearance 
of flattened cells) i  determined by the following calculation: (mean 
number o(cells with rounded, phase-dark soma/mean number o(total 
cells scored) x 109. While rounded cells typically lack filopodia0 our 
preliminary studies (below) demonstrate that soma roundness is inde- 
pendent of neurite elaboration: both flattened and roundel cells arc 
routinely observed with andwithout neurites depending upon celtum 
treatment. 
The relative extent of neurite outgrowth was quaatitatcd by com- 
parison o( neurite length with respective somal diameter (SD) as pre- 
viously deseril~d [15]. Previou~ quantitative studies of NB~'2a/dl 
neurit¢ outgrowth [15,16] have shown that the majority of undifferen- 
tiated NB2a/dl ceils possess putative neurites of <1SD, while the 
respective modal length of neurites induced, by various treatments is 
I-2 SD at 4 h, and 2-3 SD at 24 h. Accordingly, for analy~s of neurite 
induction at 4 h, the percentage of cells/culture with hearties was 
determined by the following calculation: (mean number of cells with 
;~ 1 SD neurites/mean number of total cells seored)× 100. Similarly, 
the percentage of cells/culture with neurites a  24h was determined by 
calculating (mean number ofcells with ~2 SD neurites/mean number 
of total cells scored) x 100. Values obtained in the above quantitations 
were statistically compared by Student's t.t~t as described [15,35]. 
2.4. Quantitation of tzeurottal migration 
The influence of proteases and their inhibito~ on migration was 
examined by a modification o( the technique of Mei~auer et el. [38]. 
Ceils (100 cell~'i ml) were plated in Bioeoat cell culture inserts with 
u Matrigel ba~e (Collaborative Research, Dedford, MA) within 24- 
well trays. The cells were plated in 1 ml of edium containing either 
0.8% serum or no serum, with or without one of the following: plasmin 
(10 U/ml), aprotinin (1.0 U/ml), thrombin (10 U/ml), and hirudin (5 
U/ml). Twenty-four hours later, the inserts were removed, and the 
percentage ofcells which ad migrated through the Matrigel and had 
adhered to the culture tray substratum were quantitated. Duplicate 
wells from each of two trays were examined. Additional cultures were 
plated directly into wells without inserts in the presence oftbe above 
compounds; no deterimcntal effect on cell viability or attachment to
culture plastic was observed (not shown). The 'fold change' in migra- 
tory cells was determined by dividing the mean percentage o( cells 
which had reached the culture troy substratum under various condi- 
tions by the mean percentage obtained in the pr~ence ofserum with- 
out further additions. 
2.5. Cell.free as.rays of inhibitor spectficiO, 
The specificity ofaprotinin and hirudin for plasmin and thrombin, 
respectively, was determined by degradation o( exogenous chromo- 
genie substrates essentially as previously described [16]. Chromozym- 
TH (specifically hydrolyzed by thrombin) and Chromozym-PL (spe- 
cifically hydrolyzed by plasmia) were incubated with 10 U ofplasmin 
or thrombin and degradation was monitored spectrophotometrically 
in all-free assays in the pre~ence and absence o( 10 U each ofaprotinin 
(specific inhibitor fpla~min) or hirudin (specific inhibitor f throm- 
bin) in duplicate acr.ording to the substrut¢ manufacturer's in truc- 
tions (Boehriager-Mannheim Biachemicals, lndiannapolis, IN). The 
percent inhibition f protease activity b ~tch inhibitor was deter- 
mined by the formula: [(mean anaount o(substrate hydrolyzed in the 
presence of each inhibitor/mean amount ofsubstrate hydroid/zeal in the 
absence of inhibitor) x 100]-100. We observed that, under these con- 
ditions, aprotinin inhibited plasmin activity by 97.6% but thrombin by 
only 4%, while hirudin inhibited 100% ofthrombin activity but only 
8.1% of plasmin activity. 
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3. RESULTS 
3.1. Effect of plasmin on neuroblastoma orphology 
A significant increase in the number of cells with 
rounded perikarya was observed within 4 h fellowing 
addition of plasmin (0.1 U/ml) to NB2a/dl cells in the 
presence of serum (Fig. 1). When cultures were deprived 
of ~erum to induce neurite outgrowth [15,16], plasmin 
still caused perikaryal rounding, but did not alter the 
rate and extent of neurite outgrowth (Table I; Fig. 1). 
The plasmin inhibitor, aprotinin [39], inhibited plasmin- 
dependent cell rounding, and, unlike hirudin [16,17], did 
not induce neurite outgrowth (Table I; discussed further 
below). These effects on soma morphology were specific 
since trypsin (0.1-1 U/ml) did not induce cell rounding 
within 4 h and extended (48 h) treatment resulted in 
neurite retraction simultaneously with perikaryal 
rounding (Table 1). Alteration of soma, but not neuritic, 
morphology following manipulation ofplasmin activity 
therefore suggested that plasmin was more active 
against components localized primarily on the perikar- 
yal rather than neuritic surface. 
3.2. Plasmin enhances neuronal migration 
In the presence of serum, a relatively small percentage 
of NB2a/dl cells were observed to migrate through a 
Matrigel barrier. Depletes of the thrombin-like protease 
by serum-deprival [16,17] did not alter this percentage 
(Fig. 2), nor did addition of the specific thrombin inhib- 
itor, hirudin (not shown). However, the addition of 
plasmin to serum-containing or serum-free medium in- 
creased the percentage of migratory cells by approxi- 
mately 5-fold, while the addition of aprotinin reduced 
this percentage by approximately 5-fold, 
3.3. Potentiation and enhancement of neurite outgrowth 
by inhibition of plasmin 
Aprotinin alone had no effect on neurite outgrowth 
(Tables I and II); neither did it influence the number of 
hirudin-induced neurites present at 4 h (Table II). As 
previously shown [17] culturing of cells for 24 h in the 
~ r ~  .~"':~ .... . - 
~" " , ~ '~ ' , " . . - , t "  
• . , .  . • . ,. ~ • ,~) ,  
Fig, 1. Effect of manipulation ofactivity o1" plasmin and the thrombin. 
like pretense on NB2a/dl morphology. Cells were cultured for 4 h in 
medium containing 0,8% serum (panel a), no serum (panel b), 0,8% 
serum ÷ plasmin (panel c), no serum + plasmin (panel d), 0,8% serum 
+ aprotinin (panel e) and 0.8% serum ÷ hirudin (panel f'), then were 
fixed and photographed under phase-contrast microacopy, Note that 
plantain induces rounding of cell bodies but does not retract neurites 
induced by serum deprivation (panels c, d), Note aho that plasmin 
inhibition by aprotinin dogs not indu~ neuritca (panel e) but inhibi. 
tion of the thrombin-like protcase by hiradin (panel f) induces 
neurites. 
presence of serum induced an approximate doubling of 
neurites; identical results were observed in the presence 
Table 1 
EIT~t of exogenous pretenses ar.d inhibitors on NB2a/dl morpholosy 
Conditions Time % Cells w, neurites % Rounded cells 
- serum 4 h 25.4 _ 7.3 24.7 +_ 6.5 
- serum + plasmin 4 h 19.8 +_ 5.9 58.2 "t- 15.3' 
- serum + plasmin + aprotinin 24 h 24.5 _+ 4.7 26.6 +_ 6.8 
- serum 24 h 24.7 + 6.5 24.7 +_ 10,1 
- serum + plasmin 24 h 23.8 __. 4.7 54.7 +- 7,5' 
- serum + trypsin 4 h 23.7 _+ 6.3 26.1 +_ 5,7 
- serum 48 h 67.9 _+ 4.4 22.7 _+ 2.1 
- serum + trypsin 48 h 41.8 _+ 3.3' 71.3 _ 9,1" 
• P < 0,0005 vs, -serum alone as compared by Student's/.test, All other values statistically equivalent LO those obtained for -serum alone at 
respective incubation time, N.D., not determined (see Table 11), Cells were deprived of serum and treated with plasmin or trypsin for the indicated 
times then fixed, and the % cells with neurites and the % rounded cells were separately quantitatcd under phase-contrast microscopy as describ='d 
in section 2, 
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FiB. 2, Influence of plasmin aetivRy on NB2a/dl migration. Equiva- 
lent numbers of cells were plated in medium containing serum, me- 
dium containing serum + aprotinin, medium lacking serum, and e- 
dium lacking serum ÷ plasmin into Matrigel.based inserts placed 
within 24-well trays as described insection 2. After 24 h, the number 
of cells which ad migrated through the Matrix, el base and attached 
to the culture tray substratum were quantitated by phase.contrast 
microscopy. These were considered migratory cells(see text); the num- 
ber of migrator), cells differed under each experimental condition. The 
'fold change' in migratory ceils induced by aprotinin, serum depriva- 
tion, or serum deprivation ÷ plasmin v . that observed under'control' 
conditions (i.e. medium containing serum with no further additives) 
was determined by dividing the mean percentage of cells which had 
migrated through theMatrisel to the culture tray substratum under 
each condition by themean percentage of observed under conditions. 
of aprotinin. The transient neurites induced in NB2a/dl 
cells by 4 h treatment with hirudin had retracted by 24 
h (see also [16,17,35A0]), However, hirudin-indueed 
neurites did not retract if aprotinin was also present. 
Similarly, aprotinin enhanced neurite outgrowth in- 
duced by serum deprivation. 
4. DISCUSSION 
The present study has examined the respective roles 
of two neuronal surface proteases, plasmin and a 
thrombin-like protease, in neuronal differentiation and 
Table II 
Enhancement and potentiation fneurites by plasmin inhibition 
Culture conditions % Cells with neurites 
4 h Incubation 24 h Incubation 
Serum 6.9 - 2.4 14.6 ± 1.9 
Serum * aprotinin 6.5 _+ 2.6 14.1 + 2.7 
Serum + hirudln 22.7 -+ 5.3' 13.7 _+ 2.0 
Serum + both 23.2 + 2.7" 28.0 + 8.5" 
- serum N.D. 2B.6 _+ 5.4" 
- serum + aprotinin N.D. 40.0 +_ 5.1 "° 
' p < 0.0005 vs. values obtained for serum as compared by Student's 
t.test. *" In addition, P < 0.0005 vs. values obtained for -serum an 
compared by Student's t-test. AS1 other values statistically equivalent 
to those obtained for serum or -serum at 4 or 24 h, respectively. N.D., 
not determined. Cells were deprived of serum and treated with aprot- 
inin, hirudin or both for the indicated times then fixed, a d th  % cells 
with neurites were quantitated under phase.contrast microscopy as 
described in section 2. 
neuritogenesis. Exogenous plasmin induced cell body 
rounding and increased cell migration, but neither pre- 
vented nor reversed neurite outgrowth. Rounding of 
cells following exposure to exogenous plasmin is likely 
to be a reflection of  diminished adhesion, since the per- 
centage of migratory cells was also increased. The ef- 
fects of increases or decreases in plasmin activity were 
independent of the presence or absence of  serum. Fi- 
nally, inhibition of plasmin by aprotinin suppressed mi- 
gration but did not induce neuritogenesis. The apparent 
specificity of  plasmin for the soma, rather than neuritic, 
compartment is further underscored by the simultane- 
ous withdrawl of neurites and rounding of  somata in the 
presence of trypsin. These findings for plasmin are the 
opposite to those obtained following manipulation of  
the activity of the thrombin-like protease that regulates 
NB2a/dl neuritogenesis ( ee also [16017,35,40]). How- 
ever, plasmin inhibition potentiated neurites elaborated 
in response to inhibition (by hirudin addition) or re- 
moval (by serum deprivation) of  the thrombin-like pro- 
tease. Recently, Liang and Crutcher [41] demonstrated 
preferential migration of cells in the direction of  newly 
elaborated neurites, thereby lessening the apparent ex- 
tent of neuritogenesis. NB2a/dl cells have been shown 
to continue migration following nearitogenesis, and to 
continually elaborate and resorb multiple neuritvs and 
neurite-Iike processes during the first 24 h of  induction 
by inhibition of the thrombin-like protease [16]. Ac- 
cordingly, plasmin inhibition may enhance net neurite 
outgrowth by preventing cell bodies from migrating in 
the direction of  neurites induced by hirudin or serum 
removal. Indeed, suppression of cell motility has been 
shown to be the major rate-determining event in neuri- 
togenesis in NG 10S-I 5 cells [42]. 
The physiological role of  suri~ace protease inhibition 
in neurite outgrowth in the developing brain remains 
uncertain [43]. These studies on cultured neuronal cells 
demonstrate hat plasmin and thrombin~ or a thrombin- 
like protease [l 6,17,35,40], mediate xperimentally sep- 
arable aspects of  neuronal maturation and neuritogene- 
sis. In developing brain, certain glial-derived inhibitors 
of plasminogen activators that are not active against 
thrombin [33] may initially suppress neuroblast migra- 
tion, thereby allowing glial-derived thrombin inhibitors 
to induce efficient neuritogenesis, Similar hierarchical 
effects on the early stages of neuroblastoma differentia- 
tion have been described: glial-derived extracellular ma- 
trix factors [40] including laminin [35], and inhibition of 
a pretense with calpain-like specificity [16], potentiate 
and enhance the outgrowth of the otherwise transient 
neurites induced by inhibition of  the putative thrombin- 
like proteas¢. In this regard, plasminogen binds with 
high affinity to both luminia and fibronectin [43], indi- 
cating that particular areas rich in extraeeilular matrix 
components may serve as 'reservoirs' for plasminogen 
during neuronal migration. Furthermore, neural crest 
migration on fibronectin requires urokinase-type plas- 
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minogen act ivator  activity [3]. Similarly, glial-derived 
nexin, once complexed with thrombin,  can bind to com- 
ponents of  the extracel lular matr ix  [44], Since thrombin 
adsorbs to the neuronal  p lasma membrane  [24] a tem- 
poral  physical  l inkage, mediated by a thrombin.nexin  
complex, may occur  between the neuronal  surface and 
the extracellular matr ix.  
Di f ferent iat ion o f  neurob las toma ceils by treatments 
such as retinoic acid or dbcAMP,  both o f  which induce 
neurite outgrowth  in NB2a/d l  cells [15,45], is ult imately 
accompan ied  by specific decreases in p lasminogen acti- 
vators [46,47]. In some cell systems, however,  rather 
than undergoing a uni form decrease, p lasminogen acti- 
vators become localizc:d to neuronal  growth cones [23], 
and are thought  to facilitate growth cone migrat ion 
fol lowing cessat ion o f  cell body migrat ion [1]. Whether  
or not a similar local ization of  p lasmin activity accom- 
panies cont inued NB2a/d l  neurite outgrowth and mattt- 
ration, and under what  condit ions such localization 
could be crucial for  growth  eone migrat ion and ult imate 
synaptogenesis,  remain  to be deterlnined, 
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